|
|
赤峰蒙古族目前有Y-DNA的一组数据(见附件),其组成与韩国人群非常相似,这其实与之前体质人类学认为兴安岭以南地区蒙古族可以归入满洲-朝鲜类型的结论是吻合的。这让我们联想到东胡系族群南迁之前,长城沿线的戎狄系族群和东北秽貊系族群之间的关联。
可惜赤峰蒙古族一组数据是2003年的老文献资料,其后再无后续研究,当时的分型不细,也没有STR数据供匹配分析。最近通过复旦大学分子人类学实验室的帮助,本人的Y-DNA测序完成,结果为O3-M134+,刚好落入赤峰蒙古族的第一大单倍体群(20/60,33.33%),现在STR数据也已经拿到,以目前文献发布的数据进行匹配分析,结果显示主要与东北亚沿海或者近海的通古斯系以及日韩人群匹配,同时还与西南一线的少数族裔匹配,后者对于东北亚的其他单倍体群如C3*也表现为类似的匹配情况,可能与史前的迁徙或者氐羌系族群的南下有关,这里不多讨论。在匹配人群中还包括呼伦贝尔蒙古族的2例样本,因为总样本数也只有几例,因此,可能暗示本人的单倍体型可能是东蒙地区的一个主要支系,匹配分析见附件。
复旦大学为本人测了18个STR位点,而文献资料中一般只考察6-8个,因此,无法更深入的进行匹配分析,我在韩国一组大样本量的法医数据库中进行匹配样本寻找,结果的确找到了一个非常接近的样本,仅差2部突变,可能暗示共祖年代只有近1000-2000年,或者更近。
Wells et al. (2001):
Koreans
3/45 = 6.7% D-M174
7/45 = 15.6% C-M130(xC3c-M48)
1/45 = 2.2% F-M89(xI-M170, J2-M172, H1-M52, K-M9)
1/45 = 2.2% K-M9(xL-M20, N1c-M46, O-M175, P-M45)
14/45 = 31.1% O-M175(xO1a-M119, O2a-M95, O3-M122)
16/45 = 35.6% O3-M122
2/45 = 4.4% O1a-M119
1/45 = 2.2% Q1a1-M120
Xue et al. (2006):
Korean (China)
2/25 = 8.0% Y*(xA, C, DE, J, K)
3/25 = 12.0% C3-M217(xC3c-M48)
1/25 = 4.0% K-M9(xNO-M214, P-92R7)
1/25 = 4.0% N1*-LLY22g(xN1a-M128, N1b-P43, N1c-Tat)
1/25 = 4.0% O2*-P31(xO2a-M95, O2b-SRY465)
5/25 = 20.0% O2b-SRY465(xO2b1-47z)
2/25 = 8.0% O2b1-47z
6/25 = 24.0% O3*-M122
4/25 = 16.0% O3a3c1-M117
Korean (Korea)
7/43 = 16.3% C3-M217(xC3c-M48)
1/43 = 2.3% DE-YAP(xE-SRY4064)
1/43 = 2.3% J-12f2
1/43 = 2.3% K-M9(xNO-M214, P-92R7)
1/43 = 2.3% NO-M214(xN1-LLY22g, O-M175)
1/43 = 2.3% N1*-LLY22g(xN1a-M128, N1b-P43, N1c-Tat)
1/43 = 2.3% O2*-P31(xO2a-M95, O2b-SRY465)
6/43 = 14.0% O2b-SRY465(xO2b1-47z)
6/43 = 14.0% O2b1-47z
7/43 = 16.3% O3*-M122
5/43 = 11.6% O3a3c-M134(xO3a3c1-M117)
5/43 = 11.6% O3a3c1-M117
1/43 = 2.3% P-92R7(xR1a-SRY10831.2)
Hammer et al. (2005):
7/75 = 9.3% C3-M217(xC3c-M86)
1/75 = 1.3% D2*-P37.1
2/75 = 2.7% D2a1-M125
1/75 = 1.3% N1-LLY22g(xN1a-M128, N1b-P43, N1c1-M178)
1/75 = 1.3% N1a-M128
8/75 = 10.7% O3-M122(xM134, LINE1)
15/75 = 20.0% O3a3c-M134
7/75 = 9.3% O3+LINE1
2/75 = 2.7% O1a-M119
2/75 = 2.7% O2*-P31(xO2a-M95, O2b-SRY465)
25/75 = 33.3% O2b-SRY465/P49(xO2b1-47z)
3/75 = 4.0% O2b1-47z
1/75 = 1.3% R-M207
Katoh et al. (2004):
Korean Chinese ("...collected in the northeastern part of
China")
10/79 = 12.7% C-M130(xC3c-M48)
2/79 = 2.5% D
1/79 = 1.3% J
1/79 = 1.3% K-M9(xN1c-Tat, O-M175, P-M45)
2/79 = 2.5% O-M175(xO1a-M119, O2b-SRY465, O3-M122)
38/79 = 48.1% O2b-SRY465
23/79 = 29.1% O3-M122
2/79 = 2.5% P-M45(xR1a-SRY1532)
Korean ("...collected in Seoul by the
Catholic University of Korea")
14/85 = 16.5% C-M130(xC3c-M48)
3/85 = 3.5% D
4/85 = 4.7% K-M9(xN1c-Tat, O-M175, P-M45)
2/85 = 2.4% N1c-Tat
3/85 = 3.5% O-M175(xO1a-M119, O2b-SRY465, O3-M122)
2/85 = 2.4% O1a-M119
28/85 = 32.9% O2b-SRY465
29/85 = 34.1% O3-M122
Wook Kim et al. (2007), "Lack of Association between Y-Chromosomal
Haplogroups and Prostate Cancer in the Korean
Population":
Korean, "Normal control" cases
1/110 = 0.9% Y*(xC-RPS4Y, DE-YAP, K-M9)
17/110 = 15.5% C-RPS4Y
2/110 = 1.8% K-M9(xNO-M214)
6/110 = 5.5% NO-M214(xO-M175)
3/110 = 2.7% O1a-M119
2/110 = 1.8% O2*-P31(xO2a-M95, O2b-SRY465)
19/110 = 17.3% O2b-SRY465(xO2b1-47z)
10/110 = 9.1% O2b1-47z
12/110 = 10.9% O3-M122(xLINE1, M7, M134)
10/110 = 9.1% O3+LINE1
28/110 = 25.5% O3a3c-M134
Korean, "Prostate cancer" cases
1/106 = 0.9% Y*(xC-RPS4Y, DE-YAP, K-M9)
13/106 = 12.3% C
3/106 = 2.8% K(xNO)
3/106 = 2.8% O-M175(xO1a-M119, O2-P31, O3-M122)
4/106 = 3.8% O1a-M119
1/106 = 0.9% O2*-P31(xO2a-M95, O2b-SRY465)
18/106 = 17.0% O2b-SRY465(xO2b1-47z)
11/106 = 10.4% O2b1-47z
12/106 = 11.3% O3-M122(xLINE1, M7, M134)
14/106 = 13.2% O3+LINE1
26/106 = 24.5% O3a3c-M134
Han-Jun Jin et al. (2009):
1/154 = 0.65% Y*(xC, DE, K)
23/154 = 14.9% C
3/154 = 1.9% DE
1/154 = 0.65% K(xNO)
10/154 = 6.5% NO(xO)
6/154 = 3.9% O(xO1, O2, O3)
6/154 = 3.9% O1a
8/154 = 5.2% O2(xO2a, O2b)
22/154 = 14.3% O2b(xO2b1)
9/154 = 5.8% O2b1
45/154 = 29.2% O3(xLINE1)
20/154 = 13.0% O3+LINE1 |
本帖子中包含更多资源
您需要 登录 才可以下载或查看,没有账号?注册
x
|